Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marian Benroubi
Observed names:
Benroubi M,
M Benroubi,
M. Benroubi
Institution:
Athens Euroclinic
Observed institutions:
Athens Euroclinic,
Polyclinic General Hospital,
Sandoz Group AG (Switzerland)
OpenAlex ID:
A5113435233
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
2019
·
Helena W. Rodbard
, Julio Rosenstock
, et al.
·
Diabetes Care
·
521
PDF
Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2)
2015
·
Francesco Giorgino
, Marian Benroubi
, et al.
·
Diabetes Care
·
287
Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix®30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE™ observational study
2009
·
P. Valensi
, M. Benroubi
, et al.
·
International Journal of Clinical Practice
·
90
PDF
The IMPROVE™ study - a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts
2008
·
P. Valensi
, M. Benroubi
, et al.
·
International Journal of Clinical Practice
·
89
Fear, guilt feelings and misconceptions: Barriers to effective insulin treatment in type 2 diabetes
2011
·
Marian Benroubi
·
Diabetes Research and Clinical Practice
·
54
Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix®30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE™observational study
2009
·
J. Gumprecht
, M. Benroubi
, et al.
·
International Journal of Clinical Practice
·
50
PDF
Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix®30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE™ observational study
2009
·
S. Shah
, M. Benroubi
, et al.
·
International Journal of Clinical Practice
·
50
PDF
Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study*
2009
·
Stephen Jones
, Marian Benroubi
, et al.
·
Current Medical Research and Opinion
·
47
Clinical outcomes after insulin initiation in patients with type 2 diabetes: 6-month data from the INSTIGATE observational study in five European countries
2011
·
Andreas Liebl
, Stephen Jones
, et al.
·
Current Medical Research and Opinion
·
36
Clinical outcomes after 24 months of insulin therapy in patients with type 2 diabetes in five countries: results from the TREAT study
2013
·
A. Oguz
, M. Benroubi
, et al.
·
Current Medical Research and Opinion
·
33
Clinical Outcomes After Insulin Initiation in Patients with Type 2 Diabetes: 24-Month Results from INSTIGATE
2012
·
Andreas Liebl
, Steven Jones
, et al.
·
Diabetes Therapy
·
16
PDF
Efficacy and Safety of Once Weekly Dulaglutide vs. Insulin Glargine in Combination with Metformin and Glimepiride in Type 2 Diabetes Patients (AWARD-2)
2014
·
Francesco Giorgino
, Marian Benroubi
, et al.
·
Canadian Journal of Diabetes
·
14
Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study
2009
·
Yang Wenying
, Marian Benroubi
, et al.
·
Current Medical Research and Opinion
·
14
Predictors of achieving HbA1c <7% and no hypoglycaemia 6 months after initiation of biphasic insulin aspart 30 in patients with type 2 diabetes in the IMPROVE study
2013
·
Paul Valensi
, Joseph Shaban
, et al.
·
Current Medical Research and Opinion
·
8
The patients' voice: testimonies from patients suffering from chronic disease
1995
·
A. Lacroix
, S. Jacquemet
, et al.
·
Patient Education and Counseling
·
6
Effect of the Long-Acting Somatostatin Analogue SMS 201-995 on the Glycaemic Control in Insulin-Treated Diabetics
1986
·
B. Karamanos
, G. Tolis
, et al.
·
Scandinavian Journal of Gastroenterology
·
4
Naloxone increases blood flow in the human hand.
1985
·
A G Archer
, M Benroubi
, et al.
·
The Journal of Physiology
·
2
Predictors of postprandial blood glucose response to biphasic insulin analogue therapy
2012
·
Vito Borzì
, Marian Benroubi
, et al.
·
Primary care diabetes
·
1
PDB23 Investigating Internists’ Endocrinologists’ and Paediatricians’ Attitudes in Regards to the VALUE of Innovative Diabetes Mellitus Self-Monitoring Technologies in Greece
2021
·
O. Siskou
, P. Galanis
, et al.
·
Value in Health
PDF
Clinical and Patient Reported Outcomes over the 24 Months of Insulin Therapy in Patients with Type 2 Diabetes in Greece: Data from The Instigate Study
2012
·
Kyriakos Aloumanis
, Marian Benroubi
, et al.
·
15th International & 14th European Congress of Endocrinology
Differences in health related resource use and costs before and in 24 months after insulin initiation in patients with type 2 diabetes: final data from instigate study
2012
·
Kyriakos Aloumanis
, Marian Benroubi
, et al.
·
15th International & 14th European Congress of Endocrinology
Länderspezifische Unterschiede in der Insulintherapie: Zweijahresergebnisse der INSTIGATE-Studie
2010
·
A Liebl
, S Jones
, et al.
·
Diabetologie und Stoffwechsel
Show more works
View as search
Works count:
23
Citation count:
1,322
H-index:
13
I10-index:
13
Year
Topic
Type